- Adjunctive therapy for symptomatic treatment of stable angina pectoris in patients intolerant of or unsuccessfully treated with first-line antianginal therapy:
- PO 35mg BD
- Tablet:
- 35mg
- Should be taken with food
Phenylmethylamines anti-anginal
It is believed to improve myocardial metabolism during ischemia by inhibiting partial fatty acid oxidation and enhancing utilization of glucose-dependent oxidation, which generates ATP more efficiently in a low-oxygen environment.
- Dizziness
- Headache
- Diarrhoea
- Vomiting
- Indigestion
- Abdominal pain
- Feeling sick
- Hypersensitivity to class/ingredients
- Active liver disease
- Kidney impairment
- Parkinson’s disease
- Restless legs syndrome
- Tremors
- Fluoxetine
- Lithium
- Levodopa
- Carbamazepine
- Buspirone
- Rifampicin
Drug Status
| Availability | Prescription only |
| Pregnancy | Contraindicated |
| Breastfeeding | Contraindicated |
| Schedule | Not controlled |
| BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
|---|---|---|---|---|---|
| Trita MR | 35mg | Tablet | 30’s | Medisel Kenya | Medisel Kenya |
| Vasocare | 35mg | Tablet | 30’s | Innocia Lifesciences | Wessex Pharma |
| Vastarel MR | 35mg | Tablet | 30’s | Les Laboratoires | Harley’s Ltd |